LanzaTech Global, Inc. LNZA

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived Nasdaq

Founded in 2005 in New Zealand and now headquartered in Skokie, Illinois, LanzaTech is a leading provider of carbon management and advanced conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical inputs for industry. Our mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging robust, scalable biotechnology solutions to maximize the value of domestic resources.

Gas fermentation is the centerpiece of our offering. Our proprietary process utilizes abundant, locally-sourced waste streams using existing infrastructure, turning off-gases into valuable commodities, while supporting the strategic objective of maximizing the productivity of industrial assets. The process is conducted on existing industrial land, making efficient use of available space and water resources, and driving productivity from legacy and new assets alike.

Last close 4.81 2026-10-23
Market cap $63.0M 2026-06-30 share count
52-week range 4.29 - 44.00

Valuation FY2025 figures against the last close

P/S1.1x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-22.27

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Revenue $55.8M$49.6M$62.6M$37.3M——
R&D $53.2M$77.0M$68.1M$53.2M——
SG&A $47.0M$50.0M$50.4M$26.8M$951.5K—
Total operating expenses $135.0M$158.5M$169.0M$112.9M——
Operating income -$79.2M-$108.9M-$106.4M-$75.6M-$1.4M—
Pre-tax income -$49.0M-$123.5M-$131.2M-$78.3M$46.7K—
Income tax $0$0$0$0$0—
Net income -$49.0M-$137.7M-$134.1M-$76.4M$46.7K—
EPS, basic -22.27-69.71-0.79-12.37——
EPS, diluted -22.27-69.71-0.79-12.37——
Shares, diluted (wtd. avg.) 2.2M2.0M176.0M9.3M——

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents $13.2M$43.5M$76.3M$83.7M$128.7M$0
Inventory $684.0K$2.2M$1.8M$1.1M——
Total current assets $39.7M$99.3M$172.7M$123.9M$680.9K—
Property, plant and equipment $17.1M$22.3M$22.8M$19.7M——
Total assets $100.2M$174.7M$241.6M$176.9M$150.9M—
Accounts payable $10.9M$5.3M$4.1M$7.5M$85.5K—
Total current liabilities $27.7M$30.4M$27.8M$56.0M$751.4K—
Long-term debt ——$25.1M$50.0M——
Total liabilities $90.9M$161.2M$127.2M$124.9M$11.6M—
Retained earnings -$1.02B-$969.6M-$831.9M-$456.2M-$10.7M—
Total equity -$3.9M$13.4M$114.5M-$428.7M-$354.9M$0

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Operating cash flow -$64.9M-$89.1M-$97.3M-$84.7M-$510.0K—
Depreciation and amortisation $4.2M$5.6M$5.5M$4.7M——
Stock-based compensation $7.2M$13.2M$15.2M$2.5M——
Capital expenditure $1.3M$5.3M$8.6M$10.7M——
Investing cash flow $11.2M$28.4M-$57.9M-$10.7M-$150.0M—
Financing cash flow $25.6M$30.2M$148.2M$50.5M$150.9M—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001539497-26-001238.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -200M -100M 0 100M Net income, FY2021: 46.7K Revenue, FY2022: 37.3M Net income, FY2022: -76.4M Revenue, FY2023: 62.6M Net income, FY2023: -134.1M Revenue, FY2024: 49.6M Net income, FY2024: -137.7M Revenue, FY2025: 55.8M Net income, FY2025: -49M FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — — $37.3M $62.6M $49.6M $55.8M
Gross profit — — — — — —
Net income — $46.7K -$76.4M -$134.1M -$137.7M -$49.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Results announced Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Auditor changed The company changed auditors. Sometimes routine; historically one of the more reliable warnings that something is wrong. Item 4.01
  • Auditor changed Item 4.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Material agreement signed Item 1.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%